(2020). Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Int J Nanomedicine.
Chicago-стиль цитирования"Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]." Int J Nanomedicine 2020.
MLA-цитирование"Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]." Int J Nanomedicine 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.